Comparison results
| Results: Differences Similar | ✘Keratoacanthoma of the lips and oral mucosa | ✘Oligodendroglioma | ||||
| Related research | Analogs | Analogs | ||||
| ||||||
| Distinctive symptoms | ||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||
| Register, to see more distinctive signs of diseases and studies | — | 85% | ||||
| pain from herpes | 94% | — | ||||
| brain tumor | — | 34% | ||||
| warts | 67% | — | ||||
| brain tumor | — | 30% | ||||
| facial pain | 65% | — | ||||
| main complaint headache | — | 29% | ||||
| herpes | 61% | — | ||||
| women passion | — | 28% | ||||
| keratoacanthoma of the skin | 51% | — | ||||
| very pale | — | 25% | ||||
| dense tumor | 41% | — | ||||
| headache attacks | — | 23% | ||||
| precancer | 40% | — | ||||
| speech absence | — | 22% | ||||
| red lip | 40% | — | ||||
| oncology relatives | — | 22% | ||||
| fundamental | 35% | — | ||||
| epilepsy attacks | — | 21% | ||||
| warts | 34% | — | ||||
| epilepsy | — | 20% | ||||
| skin horn | 33% | — | ||||
| heredity predisposition | — | 20% | ||||
| weakening of immunity | 32% | — | ||||
| irritability | — | 20% | ||||
| feeling of electricity | 32% | — | ||||
| visual impairment | — | 19% | ||||
| speaks poorly | 31% | — | ||||
| convulsions | — | 18% | ||||
| not sensitive to pain | 30% | — | ||||
| headaches | — | 18% | ||||
| swelling of the lips | 29% | — | ||||
| impaired lung function | — | 17% | ||||
| immunodeficiency | 29% | — | ||||
| consequences of operation | — | 17% | ||||
| human papillomavirus | 27% | — | ||||
| onset of illness | — | 16% | ||||
| says the same | 26% | — | ||||
| cancer | 19% | 30% | ||||
| sudden onset | 26% | — | ||||
| lymphopenia | 26% | — | ||||
| effects of radiation therapy | 25% | — | ||||
| small rash | 24% | — | ||||
| keratoacanthoma of the lips and oral mucosa | 23% | — | ||||
| shortened cycle | 23% | — | ||||
| bleeding | 22% | — | ||||
| speech slurred | 22% | — | ||||
| red rash | 22% | — | ||||
| papules | 21% | — | ||||
| fighting | 21% | — | ||||
| scarring | 20% | — | ||||
| surgical infections | 20% | — | ||||
| recovery period | 19% | — | ||||
| stage of recovery | 19% | — | ||||
| swelling | 18% | — | ||||
| radiation therapy | 30% | 19% | ||||
| disease operation | 25% | 16% | ||||
Instructions
Video 
|
